The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York 503B Compounding Master Guide You may have seen headlines recently claiming peptides like MOTS C or BPC 157 are back let's talk about what this means. In 2023, the FDA placed 19 commonly used peptides into Category Buy BPC 157 Peptide 99%+ Purity BPC 157 for Research Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law